Patorno E, Htoo PT, Glynn RJ, Schneeweiss S, et al. Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease. Ann Intern Med 2022;175:W4-W5.
PMID: 35038404